Report finds China targeted AstraZeneca in fraud probe over cancer treatment

Report finds China targeted AstraZeneca in fraud probe over cancer treatment

Pharmaceutical giant AstraZeneca, whose China president is under investigation, was previously investigated for medical insurance fraud cases involving cancer medication sales, according to new Chinese media reports. The news comes after the British-Swedish company announced on its official website last week that its China chief Leon Wang was cooperating “with an ongoing investigation”, and its … Read more

Pfizer’s cancer drug combo improves overall survival in late-stage study

Pfizer’s cancer drug combo improves overall survival in late-stage study

Pfizer said on Thursday a combination of its drugs, Talzenna and Xtandi, helped prolong the lives of patients with a type of advanced prostate cancer in a late-stage study. The drug combination showed a significant improvement in the overall survival in patients with metastatic castration-resistant prostate cancer (mCRPC) regardless of the presence of a mutation, … Read more